Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2020 | 11-2019 | 11-2018 | 11-2017 | 11-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,242 | -21,699 | -9,428 | N/A | N/A |
| Depreciation Amortization | 2,453 | 2,245 | 2,634 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,234 | 302 | -519 | N/A | N/A |
| Other Working Capital | 36,408 | 19,545 | -25,306 | N/A | N/A |
| Other Operating Activity | 3,067 | 208 | 944 | 0 | 0 |
| Operating Cash Flow | $-80 | $601 | $-31,675 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,553 | -1,651 | -1,589 | N/A | N/A |
| Purchase Of Investment | -275,224 | -9,351 | -12,917 | N/A | N/A |
| Sale Of Investment | 25,373 | 19,500 | 54,500 | N/A | N/A |
| Investing Cash Flow | $-254,404 | $8,498 | $39,994 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 219,117 | 142 | 531 | N/A | N/A |
| Common Stock Repurchased | -7 | -16 | -2 | N/A | N/A |
| Other Financing Activity | 119,914 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $339,024 | $126 | $529 | $N/A | $N/A |
| Beginning Cash Position | 34,986 | 25,761 | 16,913 | N/A | N/A |
| End Cash Position | 119,526 | 34,986 | 25,761 | N/A | N/A |
| Net Cash Flow | $84,540 | $9,225 | $8,848 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -80 | 601 | -31,675 | N/A | N/A |
| Capital Expenditure | -4,553 | -1,651 | -1,595 | N/A | N/A |
| Free Cash Flow | -4,633 | -1,050 | -33,270 | 0 | 0 |